Enzyme Kinetics and Regulation (1A) - Bio & Biochem

A lab studies acetylcholinesterase (AChE) kinetics at 25°C in buffer (pH 7.0). With no inhibitor, $V_{max}=120\ \mu$ M/min and $K_m=50\ \mu$ M for acetylthiocholine. With 10 nM compound X, $V_{max}$ remains 120 $\mu$ M/min but apparent $K_m$ increases to 200 $\mu$ M. Based on these results, what effect does compound X have on AChE function?
Answer: Competitive inhibition that increases apparent $K_m$ without changing $V_{max}$ This question tests recognition of competitive inhibition patterns in enzyme kinetics. Competitive inhibitors compete with substrate for the active site, which can be overcome by increasing substrate concentration, thus leaving Vmax unchanged while increasing the apparent Km. The data shows compound X causes a 4-fold increase in apparent Km (from 50 to 200 μM) while Vmax remains at 120 μM/min, which is the classic signature of competitive inhibition. The correct answer B accurately identifies this pattern, while option C incorrectly suggests noncompetitive inhibition would leave Km unchanged, when noncompetitive inhibitors actually decrease Vmax without affecting Km. To identify competitive inhibition, check if only Km increases while Vmax stays constant - this indicates the inhibitor can be outcompeted by excess substrate.
A mitochondrial dehydrogenase uses NAD $^+$ as a co-substrate. Initial velocities were measured at saturating substrate (10× $K_m$ ) while varying NAD $^+$ at 37°C. Adding 1 mM nicotinamide (a product analog) decreased the apparent $V_{max}$ for NAD $^+$ without changing the apparent $K_m$ for NAD $^+$ . Based on the scenario, what effect does nicotinamide most likely have on enzyme function with respect to NAD $^+$ ?
Answer: Noncompetitive inhibition versus NAD $^+$ , decreasing apparent $V_{max}$ without changing apparent $K_m$ This question tests understanding of noncompetitive inhibition in multi-substrate enzyme reactions. Noncompetitive inhibitors bind to sites other than the active site and cannot be overcome by increasing substrate concentration, resulting in decreased Vmax with unchanged Km. The experiment shows nicotinamide (a product analog) decreases apparent Vmax for NAD⁺ without changing apparent Km when the other substrate is saturating, indicating nicotinamide binds to a site distinct from the NAD⁺ binding site. The correct answer B properly identifies this as noncompetitive inhibition with respect to NAD⁺, while option A incorrectly suggests competitive inhibition would not affect Vmax. To recognize noncompetitive inhibition, look for decreased Vmax with unchanged Km - this pattern indicates the inhibitor reduces catalytic efficiency regardless of substrate concentration.
A liver enzyme involved in amino acid catabolism follows Michaelis–Menten kinetics with $V_{max}=120$ nmol/min and $K_m=30$ µM at 37°C. In the presence of inhibitor Z, $V_{max}$ remains 120 nmol/min but the apparent $K_m$ increases to 90 µM. Which condition would most likely restore the original reaction rate at a given time point?
Answer: Increase substrate concentration substantially This question probes strategies to overcome enzyme inhibition in kinetics and regulation, emphasizing how to restore activity in competitive scenarios. In competitive inhibition, increasing substrate concentration can outcompete the inhibitor for the active site, restoring the reaction rate toward uninhibited levels without altering Vmax. For this liver enzyme, inhibitor Z increases apparent Km threefold while Vmax stays constant, indicating competitive inhibition where higher substrate is needed for equivalent velocity. Answer C is appropriate because substantially increasing substrate overcomes the raised Km, logically restoring the original rate by achieving saturation. Distractor A, increasing enzyme concentration, is misleading as it would proportionally raise Vmax, potentially overcompensating rather than precisely restoring the original rate, misconstruing the fixed Vmax in competitive inhibition. For analogous questions, determine inhibition type first; for competitive, test if high substrate mitigates effects. Consider the physiological context: cells often regulate via substrate availability to counter such inhibition.
Two isoenzymes catalyze the same reaction in different tissues. Under identical conditions, Isoenzyme 1 has $K_m=2$ µM and $V_{max}=80$ nmol/min; Isoenzyme 2 has $K_m=20$ µM and $V_{max}=200$ nmol/min. At a substrate concentration of 3 µM, which statement is most consistent with Michaelis–Menten behavior?
Answer: Isoenzyme 1 will operate closer to saturation and thus can have a higher rate at low substrate This question tests application of the Michaelis-Menten equation to compare enzyme activities at subsaturating substrate concentrations. At 3 μM substrate, Isoenzyme 1 (Km = 2 μM) is operating at 3/(2+3) = 60% of its Vmax (48 nmol/min), while Isoenzyme 2 (Km = 20 μM) operates at only 3/(20+3) = 13% of its Vmax (26 nmol/min). Despite Isoenzyme 2's higher Vmax, Isoenzyme 1 achieves a higher rate at this low substrate concentration because it operates much closer to saturation due to its lower Km (higher substrate affinity). This illustrates why low-Km enzymes are advantageous in physiological conditions where substrate is limiting. A common error is assuming the enzyme with higher Vmax always has the higher rate (choice A), but this is only true at saturating substrate concentrations. To compare enzyme rates at specific substrate concentrations: (1) use v = Vmax[S]/(Km+[S]) for each enzyme, and (2) remember that at low [S], the enzyme with lower Km will operate at a higher fraction of its Vmax.
An uncompetitive inhibitor halves apparent Km and Vmax. How does the Lineweaver-Burk slope change?
Answer: Stays the same Uncompetitive inhibition divides both apparent Km and Vmax by the same factor. The Lineweaver-Burk slope is Km/Vmax, so (Km/2)/(Vmax/2) = Km/Vmax, unchanged. The tempting error is thinking only Vmax decreases, which would double the slope.
Investigators measured initial velocities of purified human phosphofructokinase-1 (PFK-1) at 37°C, pH 7.4, with saturating ATP (5 mM) and varying fructose-6-phosphate (F6P). In the presence of 2 mM citrate, the apparent $K_{0.5}$ for F6P increased, while $V_{max}$ was unchanged. Which interpretation best describes citrate's effect on PFK-1 under these conditions?
Answer: Citrate acts as an allosteric inhibitor that decreases apparent substrate affinity without changing catalytic capacity This question tests understanding of allosteric regulation in enzyme kinetics, specifically how citrate affects phosphofructokinase-1 (PFK-1). Allosteric inhibitors bind at sites distinct from the active site and can alter enzyme affinity for substrate without affecting the maximum catalytic capacity. In this experiment, citrate increases the apparent K₀.₅ (the substrate concentration at half-maximal velocity for allosteric enzymes) while leaving Vmax unchanged, which is characteristic of K-type allosteric inhibition that decreases substrate affinity. The correct answer A accurately describes this mechanism, while option B incorrectly suggests competitive inhibition would decrease Vmax, which contradicts the fundamental property that competitive inhibitors only affect Km. To identify allosteric K-type inhibition, look for increased K₀.₅ or Km with unchanged Vmax, indicating the inhibitor makes substrate binding less favorable without affecting the enzyme's catalytic capacity when saturated.
A cytosolic enzyme in the pentose phosphate pathway is tested at 37°C. Under baseline conditions, the enzyme displays a hyperbolic $v$ vs. $[S]$ curve. After adding a regulatory protein Z, the $v$ vs. $[S]$ relationship becomes sigmoidal, but the maximal rate at very high substrate concentration is similar to baseline. Which mechanism is most consistent with protein Z's effect?
Answer: Induction of cooperative substrate binding through allosteric regulation This question tests recognition of cooperative binding induced by allosteric regulation. The transition from a hyperbolic to sigmoidal velocity versus substrate curve is the hallmark of positive cooperativity, where binding of substrate to one site increases affinity at other sites. Protein Z acts as an allosteric regulator that induces cooperative substrate binding, changing the enzyme from Michaelis-Menten to sigmoidal kinetics while maintaining similar maximal velocity at saturating substrate. The correct answer D identifies this as induction of cooperativity through allosteric regulation, while option C incorrectly suggests competitive inhibition would maintain a hyperbolic curve shape. To identify cooperative binding, look for the characteristic S-shaped (sigmoidal) curve that replaces the typical hyperbolic Michaelis-Menten curve, indicating multiple substrate binding events influence each other.
An enzyme in fatty acid synthesis was assayed at 30°C with and without inhibitor Q. Inhibitor Q decreased both $V_{max}$ and apparent $K_m$ by the same factor, and the Lineweaver–Burk plots were parallel. Based on these results, what effect does inhibitor Q have on enzyme function?
Answer: Uncompetitive inhibition This question assesses recognition of uncompetitive inhibition in enzyme kinetics and regulation, using changes in kinetic parameters and plot characteristics. Uncompetitive inhibition binds only the ES complex, decreasing both Vmax and apparent Km proportionally, resulting in parallel Lineweaver-Burk plots as the inhibitor traps the complex. In the fatty acid synthesis enzyme assay, inhibitor Q reduces both parameters equally, with parallel plots, matching uncompetitive traits. Answer C follows because the proportional decreases and parallel lines are hallmarks of uncompetitive inhibition, logically fitting the data. Distractor B, competitive inhibition, is incorrect as it increases Km without affecting Vmax, ignoring the observed Vmax reduction. In similar scenarios, check for parallel LB plots; if present with lowered Km and Vmax, it's uncompetitive. Differentiate from noncompetitive: uncompetitive lowers Km, while noncompetitive typically does not.
A regulator binds outside the active site and raises apparent Km with Vmax unchanged. Best classification?
Answer: Allosteric inhibition A regulator that binds away from the active site is by definition allosteric. Even though raising apparent Km while leaving Vmax unchanged looks like classic competitive kinetics, that pattern identifies the kinetic effect, not the binding site. The tempting wrong answer is competitive inhibition, but competitive inhibitors must bind at the active site, which the question rules out.
A kinase in a signaling pathway was studied at constant enzyme concentration. When an allosteric inhibitor was added, the maximal velocity decreased, and increasing substrate concentration did not restore the original maximal rate. Based on the scenario, what effect does the inhibitor have on enzyme function?
Answer: Noncompetitive inhibition that lowers $V_{max}$ even at saturating substrate This question examines inhibition types in enzyme kinetics and regulation, specifically identifying when Vmax cannot be restored by substrate. Noncompetitive inhibition binds outside the active site, affecting both free enzyme and ES complex, decreasing Vmax irreversibly with respect to substrate concentration while often leaving Km unchanged. For this signaling kinase, the allosteric inhibitor reduces maximal velocity, and high substrate fails to restore it, indicating non-recoverable catalytic impairment. Answer B is correct as the lowered Vmax unrecoverable by substrate aligns with noncompetitive inhibition, where the inhibitor diminishes active enzyme proportion. Distractor A, competitive inhibition, is wrong because it allows Vmax recovery at high substrate, misconstruing the persistent Vmax reduction. For related questions, test if high substrate overcomes inhibition; failure suggests noncompetitive or uncompetitive. Visualize Lineweaver-Burk: same x-intercept but higher y-intercept confirms noncompetitive.
An enzyme remains activated after extensive dialysis. Which mechanism most likely explains it?
Answer: Covalent phosphorylation Dialysis removes small molecules and noncovalent ligands, but covalent modifications stay attached. Covalent phosphorylation is a permanent enzyme modification that survives dialysis, keeping the enzyme active. The tempting wrong answer is allosteric activation, which relies on a reversibly bound activator that dialysis would wash away.
An enzyme in heme biosynthesis requires a divalent metal cofactor. Under identical assay conditions (37°C, pH 7.4), adding EDTA reduces the initial rate by 70%. Subsequent addition of excess Mg $^{2+}$ restores the rate to baseline. Which explanation best accounts for these observations?
Answer: EDTA chelates the required metal cofactor, reducing formation of the active holoenzyme This question tests understanding of metal cofactor requirements in enzyme catalysis and the role of chelating agents. EDTA (ethylenediaminetetraacetic acid) is a chelating agent that binds divalent metal ions, removing them from solution and from metalloenzymes. The 70% reduction in activity upon EDTA addition indicates the enzyme requires a metal cofactor for catalysis, and the complete restoration of activity with excess Mg2+ confirms this metal can serve as the cofactor. This demonstrates that the enzyme exists in equilibrium between the inactive apoenzyme (without metal) and active holoenzyme (with metal bound), and EDTA shifts this equilibrium by sequestering the metal. A common misconception is that EDTA directly inhibits the enzyme active site (choice B), but its effect is indirect through metal chelation, which is why adding excess metal reverses the inhibition. To identify metal cofactor requirements: (1) reversible inhibition by EDTA that's overcome by adding divalent metals indicates a metalloenzyme, and (2) the metal is essential for catalysis, not just for structural stability, since activity is directly affected.
In a regulation study of aspartate transcarbamoylase (ATCase) at 25°C, adding CTP reduces activity at a given [aspartate], while adding ATP increases activity. The maximal rate at very high [aspartate] is similar across conditions. Which statement best describes these effectors?
Answer: CTP and ATP act as allosteric modulators that shift apparent substrate affinity without necessarily changing $V_{max}$ This question probes allosteric regulation in enzyme kinetics, highlighting effector impacts on affinity without Vmax changes. Allosteric modulators bind distant sites, shifting conformational equilibria to alter substrate affinity (K0.5) in cooperative enzymes, often without affecting maximal catalytic rate. For ATCase, CTP decreases activity and ATP increases it at fixed aspartate, but high aspartate yields similar Vmax, indicating affinity modulation. Answer C fits as CTP and ATP act allosterically to adjust K0.5, consistent with feedback regulation. Distractor B is wrong, as competitive or irreversible would not allow Vmax similarity, confusing site and mechanism. For analogous problems, check if Vmax is constant; if yes, it's likely affinity-based regulation. Relate to pathway control: end-products like CTP inhibit early steps.
An investigator studies an enzyme that is inhibited by product P. In steady-state assays, adding P decreases the initial rate, and increasing substrate concentration partially restores the rate, but even at very high substrate the maximal rate remains lower than control. Which inhibition model best fits these findings?
Answer: Mixed inhibition, because both apparent $K_m$ and $V_{max}$ are affected This question tests recognition of mixed inhibition, which combines features of both competitive and noncompetitive inhibition. The key observations are that increasing substrate partially restores activity (suggesting a competitive component) but cannot fully restore the original Vmax (indicating a noncompetitive component). In mixed inhibition, the inhibitor can bind to both free enzyme and the enzyme-substrate complex, typically with different affinities, affecting both substrate binding (Km) and catalytic efficiency (Vmax). This is common in product inhibition where the product can bind to multiple enzyme forms. A common error is thinking this must be pure competitive inhibition because substrate partially overcomes it (choice A), but pure competitive inhibition would allow full restoration of activity at high substrate. To identify mixed inhibition: (1) look for partial restoration of activity with increased substrate that plateaus below the original Vmax, and (2) remember that mixed inhibition affects both apparent Km and Vmax, unlike pure competitive or noncompetitive inhibition.
In a comparative analysis, enzyme E from a thermophilic bacterium and a human ortholog were assayed at 70°C with identical substrate concentrations. The thermophile enzyme shows robust activity, while the human enzyme shows minimal activity. Which explanation most directly accounts for the difference?
Answer: The human enzyme likely denatures at 70°C, reducing functional enzyme concentration and $V_{max}$ This question tests temperature effects on enzyme stability in kinetics and regulation, comparing orthologs. High temperatures can denature enzymes, unfolding structure and reducing functional concentration, thus lowering Vmax as active sites are lost. At 70°C, the human enzyme shows minimal activity versus the thermophile's robust performance, suggesting denaturation. Answer A is logical as human enzymes typically denature above physiological temperatures, directly explaining the activity difference. Distractor D is wrong, as increased diffusion would enhance, not diminish, activity, ignoring denaturation. For related questions, consider optimal temperature; exceeding it causes denaturation. Relate to evolution: thermophiles have stabilized proteins for high heat.
A metabolic enzyme is inhibited by its product P. When P is added to the assay, the apparent $K_m$ increases while $V_{max}$ is unchanged. Which mechanism is most consistent with product P's effect?
Answer: P binds the active site and competes with substrate (competitive inhibition) This question probes product inhibition mechanisms in enzyme kinetics and regulation, a feedback control. Competitive product inhibition occurs when the product binds the active site, competing with substrate and increasing apparent Km without changing Vmax. For the metabolic enzyme, product P raises Km while Vmax remains constant, consistent with competition. Answer D is appropriate as this pattern indicates P competes at the active site, likely due to structural similarity. Distractor B, noncompetitive, is incorrect because it decreases Vmax, not matching the unchanged maximum. In similar problems, check parameter changes; increased Km with same Vmax suggests competitive feedback. This is common in pathways to prevent product buildup.
A kinase in a signaling pathway follows Michaelis–Menten kinetics with $K_m=8$ µM for its peptide substrate and $V_{max}=200$ pmol/min under standard conditions (37°C, pH 7.4). A point mutation in the substrate-binding pocket leaves $V_{max}$ unchanged but increases $K_m$ to 32 µM. Which interpretation best matches these data?
Answer: The mutation decreases substrate affinity but does not alter catalytic turnover at saturation This question tests understanding of how mutations affect enzyme kinetic parameters, specifically distinguishing between effects on substrate binding versus catalytic efficiency. The mutation increases Km from 8 to 32 μM (4-fold increase) while leaving Vmax unchanged at 200 pmol/min, indicating that substrate binding affinity is reduced but the catalytic machinery remains intact. Since Km represents the substrate concentration at half-maximal velocity, a higher Km means weaker substrate binding, requiring more substrate to achieve the same fractional saturation. The unchanged Vmax confirms that once substrate is bound, the enzyme catalyzes the reaction at the same maximum rate, ruling out effects on kcat or enzyme concentration. A common misconception is that increased Km might indicate improved catalytic efficiency (choice C), but Km reflects binding affinity, not catalytic rate. To analyze mutation effects on enzyme kinetics: (1) increased Km with unchanged Vmax indicates reduced substrate affinity, and (2) changes in Vmax would indicate effects on catalytic rate (kcat) or enzyme concentration.
A dehydrogenase in the TCA cycle uses NAD $^+$ as a cosubstrate. In vitro, increasing NAD $^+$ from 0.1 mM to 1.0 mM increases $v_0$ at fixed [primary substrate] = 5 µM, but $v_0$ plateaus as NAD $^+$ exceeds 2.0 mM. Which explanation best accounts for the plateau at high NAD $^+$ under these conditions?
Answer: The enzyme becomes saturated with NAD $^+$ , so further increases do not increase rate at fixed primary substrate This question tests understanding of enzyme saturation kinetics with cosubstrates in multi-substrate reactions. The dehydrogenase follows ordered or random bi-bi kinetics where both the primary substrate and NAD+ must bind for catalysis. At fixed primary substrate concentration (5 μM), increasing NAD+ initially increases the rate as more enzyme-NAD+ complexes form, but the rate plateaus when NAD+ concentration is high enough that essentially all enzyme molecules capable of binding the primary substrate have NAD+ bound. The plateau represents saturation with respect to NAD+ at the given primary substrate concentration, not inhibition or transport limitation. A common misconception is that NAD+ might inhibit at high concentrations (choice B), but the plateau at constant velocity indicates saturation, not inhibition which would decrease velocity. To analyze cosubstrate effects: (1) each substrate can saturate independently at fixed concentration of the other substrate, and (2) the maximum rate achieved by varying one substrate depends on the fixed concentration of the other substrate.
In a kinetic experiment on an enzyme involved in purine salvage, initial velocity was measured at fixed [enzyme] and pH 7.0. Adding inhibitor Q decreased $V_{max}$ from 100 to 50 µmol/min and decreased apparent $K_m$ from 20 to 10 µM. Based on these changes, Q most likely acts as which type of inhibitor (with respect to the substrate)?
Answer: Uncompetitive inhibitor This question tests recognition of uncompetitive inhibition through changes in kinetic parameters. Uncompetitive inhibitors bind only to the enzyme-substrate complex (not free enzyme), creating a unique pattern where both Vmax and apparent Km decrease proportionally. The data shows Vmax decreasing from 100 to 50 μmol/min (50% reduction) and Km decreasing from 20 to 10 μM (also 50% reduction), maintaining their ratio constant, which is diagnostic for uncompetitive inhibition. This occurs because the inhibitor effectively removes ES complexes from the reaction, lowering both the maximum rate and the substrate concentration needed for half-maximal velocity. A common error is assuming that any decrease in Km must be beneficial (indicating higher affinity), but in uncompetitive inhibition, the decreased Km simply reflects the lower substrate concentration needed to achieve half of the now-reduced Vmax. To identify uncompetitive inhibition: (1) look for proportional decreases in both Vmax and Km, and (2) remember that on a Lineweaver-Burk plot, uncompetitive inhibition produces parallel lines.
A drug candidate inhibits an enzyme in cholesterol synthesis. In vitro, increasing substrate concentration does not restore activity, and both $V_{max}$ and apparent $K_m$ decrease. Based on these results, what effect does the drug most likely have on enzyme function?
Answer: Uncompetitive inhibition This question tests uncompetitive inhibition identification in enzyme kinetics and regulation, using parameter changes. Uncompetitive inhibitors bind only ES, decreasing both Vmax and Km, preventing activity restoration by substrate as they stabilize the complex. In the cholesterol synthesis enzyme, the drug lowers both parameters and resists substrate increase, matching uncompetitive. Answer B is logical because the dual decreases without restoration fit uncompetitive inhibition. Distractor A, competitive, is incorrect as it increases Km with recoverable Vmax, missing the Vmax drop. In similar questions, see if both parameters decrease; if yes, it's uncompetitive. Use LB plots: parallel shifts confirm this type.

Start this quiz